I

InDex Pharmaceuticals Holding AB
STO:FLERIE

Watchlist Manager
InDex Pharmaceuticals Holding AB
STO:FLERIE
Watchlist
Price: 45.3 SEK 1.59% Market Closed
Market Cap: 3.5B SEK
Have any thoughts about
InDex Pharmaceuticals Holding AB?
Write Note

Cash Flow Statement

Cash Flow Statement
InDex Pharmaceuticals Holding AB

Rotate your device to view
Cash Flow Statement
Currency: SEK
Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Operating Cash Flow
Net Income
(15)
(30)
(25)
(73)
(69)
(80)
(82)
(82)
(80)
(72)
(84)
(88)
(95)
(92)
(73)
(57)
(43)
(70)
(90)
(103)
(112)
(92)
(68)
(103)
(129)
(20)
(58)
(107)
(68)
(205)
(276)
Depreciation & Amortization
(0)
0
(0)
1
0
0
0
1
1
1
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
Other Non-Cash Items
0
0
0
1
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(3)
(12)
(20)
(51)
(74)
(44)
(31)
(10)
20
24
12
76
179
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
Change in Working Capital
(17)
(20)
(25)
4
(3)
7
10
3
5
3
12
2
5
(16)
(25)
(14)
(16)
(9)
4
(10)
(3)
8
1
16
25
28
11
44
6
14
25
Cash from Operating Activities
(32)
N/A
(50)
-58%
(51)
-1%
(67)
-32%
(72)
-7%
(73)
-2%
(73)
+1%
(79)
-8%
(74)
+6%
(68)
+8%
(71)
-4%
(85)
-20%
(89)
-4%
(108)
-22%
(97)
+10%
(71)
+27%
(57)
+19%
(78)
-36%
(88)
-13%
(124)
-41%
(134)
-8%
(134)
+0%
(139)
-4%
(129)
+7%
(134)
-4%
(1)
+99%
(25)
-2 209%
(38)
-51%
(49)
-28%
(114)
-135%
(71)
+37%
Investing Cash Flow
Capital Expenditures
0
0
0
0
0
0
0
0
0
0
0
0
0
(4)
(1)
(1)
(1)
3
(0)
0
0
0
0
0
0
0
0
0
0
0
0
Other Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(2)
34
Cash from Investing Activities
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
(4)
N/A
(1)
+78%
(1)
-2%
(1)
N/A
3
N/A
(0)
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
(2)
N/A
34
N/A
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
0
0
0
37
37
37
124
130
130
130
44
0
488
488
487
487
0
0
0
0
0
0
0
0
0
607
607
Net Issuance of Debt
0
0
0
(1)
0
0
0
(1)
(0)
(0)
(1)
(1)
(1)
2
(1)
(2)
(2)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
Other
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(34)
(35)
Cash from Financing Activities
0
N/A
0
N/A
0
N/A
(1)
N/A
0
N/A
0
N/A
0
N/A
37
N/A
36
-1%
36
-1%
122
+238%
129
+6%
129
+0%
132
+2%
43
-68%
(1)
N/A
486
N/A
483
-1%
486
+1%
486
+0%
(1)
N/A
(1)
+8%
(1)
+15%
(1)
+4%
(1)
-4%
(1)
+0%
(1)
-19%
(1)
-2%
(1)
+4%
572
N/A
572
0%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
12
20
51
75
47
37
19
(8)
(12)
(0)
0
0
Net Change in Cash
(32)
N/A
(50)
-58%
(51)
-1%
(68)
-34%
(72)
-6%
(73)
-2%
(73)
+1%
(42)
+42%
(38)
+10%
(32)
+15%
51
N/A
44
-14%
40
-8%
20
-50%
(55)
N/A
(73)
-32%
428
N/A
408
-5%
401
-2%
375
-7%
(115)
N/A
(83)
+28%
(65)
+22%
(84)
-29%
(98)
-17%
17
N/A
(35)
N/A
(51)
-47%
(50)
+2%
457
N/A
534
+17%
Free Cash Flow
Free Cash Flow
(32)
N/A
(50)
-58%
(51)
-1%
(67)
-32%
(72)
-7%
(73)
-2%
(73)
+1%
(79)
-8%
(74)
+6%
(68)
+8%
(71)
-4%
(85)
-20%
(89)
-4%
(112)
-26%
(98)
+12%
(72)
+27%
(58)
+19%
(75)
-28%
(88)
-17%
(124)
-41%
(134)
-8%
(134)
+0%
(139)
-4%
(129)
+7%
(134)
-4%
(1)
+99%
(25)
-2 209%
(38)
-51%
(49)
-28%
(114)
-135%
(71)
+37%

See Also

Discover More